Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedMay 30, 2025
DataAggregated Company Financials
Companies25
  • 7D0.5%
  • 3M-16.9%
  • 1Y-18.2%
  • YTD-11.7%

Over the last 7 days, the Pharma industry has dropped 3.2%, driven by Camurus declining 4.4%. On the other hand Cinclus Pharma Holding is actually up 36%. Overall the industry is down 13% in 12 months. Earnings are forecast to grow by 49% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 30 May 2025SEK 44.2bSEK 4.8b-SEK 578,703,798.6161.8x-76.5x9.2x
Sun, 27 Apr 2025SEK 49.1bSEK 4.8b-SEK 917,745,943.1971.1x-53.5x10.3x
Tue, 25 Mar 2025SEK 52.5bSEK 4.7b-SEK 809,348,956.3375x-64.8x11.2x
Thu, 20 Feb 2025SEK 54.0bSEK 4.7b-SEK 796,512,649.5788.4x-67.8x11.5x
Sat, 18 Jan 2025SEK 50.2bSEK 4.4b-SEK 580,988,455.36125.5x-86.4x11.3x
Mon, 16 Dec 2024SEK 49.7bSEK 4.4b-SEK 615,883,468.75129.8x-80.8x11.2x
Wed, 13 Nov 2024SEK 52.5bSEK 4.4b-SEK 639,905,315.27129.1x-82x11.8x
Fri, 11 Oct 2024SEK 64.8bSEK 5.9b-SEK 1,157,189,987.12171.2x-56x11x
Sun, 08 Sep 2024SEK 67.8bSEK 5.9b-SEK 1,170,139,603.50176.9x-58x11.5x
Tue, 06 Aug 2024SEK 64.7bSEK 5.6b-SEK 992,815,736.3090.5x-65.2x11.6x
Thu, 04 Jul 2024SEK 65.7bSEK 6.4b-SEK 862,422,912.8076.3x-76.2x10.3x
Sat, 01 Jun 2024SEK 60.2bSEK 6.4b-SEK 766,392,647.4174.3x-78.6x9.5x
Mon, 29 Apr 2024SEK 48.6bSEK 6.3b-SEK 950,949,196.2765.4x-51.1x7.7x
Wed, 27 Mar 2024SEK 52.9bSEK 6.2b-SEK 1,038,115,045.0777.1x-50.9x8.5x
Fri, 23 Feb 2024SEK 46.8bSEK 6.2b-SEK 1,038,807,098.4582.5x-45x7.5x
Sun, 21 Jan 2024SEK 68.2bSEK 9.5b-SEK 1,182,202,468.0062.3x-57.7x7.2x
Tue, 19 Dec 2023SEK 66.4bSEK 9.4b-SEK 1,184,273,661.0061.9x-56.1x7x
Thu, 16 Nov 2023SEK 58.4bSEK 9.5b-SEK 1,230,435,744.0095.5x-47.5x6.2x
Sat, 14 Oct 2023SEK 50.9bSEK 9.2b-SEK 1,181,413,707.00101.4x-43.1x5.5x
Mon, 11 Sep 2023SEK 50.8bSEK 9.2b-SEK 1,177,925,858.00137.5x-43.1x5.5x
Wed, 09 Aug 2023SEK 51.6bSEK 8.9b-SEK 1,396,149,866.0085.7x-36.9x5.8x
Fri, 07 Jul 2023SEK 48.1bSEK 8.4b-SEK 1,693,639,315.0073.7x-28.4x5.7x
Sun, 04 Jun 2023SEK 47.9bSEK 8.4b-SEK 1,608,786,861.0076.5x-29.8x5.7x
Tue, 02 May 2023SEK 47.1bSEK 8.1b-SEK 1,817,383,597.0096.9x-25.9x5.8x
Thu, 30 Mar 2023SEK 44.4bSEK 8.0b-SEK 1,793,688,371.0084.7x-24.7x5.6x
Sat, 25 Feb 2023SEK 44.5bSEK 8.0b-SEK 1,845,412,023.00221.7x-24.1x5.5x
Mon, 23 Jan 2023SEK 48.9bSEK 7.3b-SEK 1,938,336,904.00278.2x-25.2x6.7x
Wed, 21 Dec 2022SEK 48.7bSEK 7.3b-SEK 1,910,539,837.00276.3x-25.5x6.7x
Fri, 18 Nov 2022SEK 48.9bSEK 7.1b-SEK 1,904,685,165.0049.4x-25.7x6.8x
Sun, 16 Oct 2022SEK 49.3bSEK 7.0b-SEK 1,754,682,602.0047x-28.1x7.1x
Tue, 13 Sep 2022SEK 52.4bSEK 7.0b-SEK 1,737,055,214.0055.1x-30.1x7.5x
Thu, 11 Aug 2022SEK 53.7bSEK 6.9b-SEK 1,535,730,526.0041.8x-34.9x7.8x
Sat, 09 Jul 2022SEK 54.8bSEK 5.9b-SEK 1,509,116,648.0041.9x-36.3x9.3x
Mon, 06 Jun 2022SEK 54.2bSEK 5.9b-SEK 1,505,666,101.0044.6x-36x9.1x
Price to Earnings Ratio

-36x


Total Market Cap: SEK 54.2bTotal Earnings: -SEK 1,505,666,101.00Total Revenue: SEK 5.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -48.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.3x is lower than the industry's current PS ratio of 9.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 6.5% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.37%
Healthcare1.58%
Pharma0.53%
Pharma0.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SECARE SwedencareSEK 40.306.3%
+SEK 383.6m		-31.9%PE69.5x
DICOT Dicot PharmaSEK 0.5014.8%
+SEK 128.6m		80.5%PB11.3x
ALZCUR AlzeCure PharmaSEK 2.9313.1%
+SEK 30.0m		43.6%PB16.1x
MOB Moberg PharmaSEK 9.337.3%
+SEK 29.7m		-63.4%PS33.9x
CESSA CessatechDKK 13.467.3%
+DKK 16.0m		125.1%PS188.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IRLAB A

SEK 7.53

IRLAB Therapeutics

7D

5.2%

1Y

-51.7%

DICOT

SEK 0.50

Dicot Pharma

7D

14.8%

1Y

80.5%

CESSA

DKK 13.46

Cessatech

7D

7.3%

1Y

125.1%

ORX

SEK 14.72

Orexo

7D

-4.9%

1Y

-26.4%

CAMX

SEK 505.00

Camurus

7D

-0.3%

1Y

-13.1%

KLAR

SEK 0.43

Klaria Pharma Holding AB (publ.)

7D

-48.4%

1Y

-17.6%

CINPHA

SEK 14.56

Cinclus Pharma Holding

7D

-7.5%

1Y

n/a

ERMA

SEK 2.69

Enorama Pharma

7D

-6.3%

1Y

15.5%

SECARE

SEK 40.30

Swedencare

7D

6.3%

1Y

-31.9%

MOB

SEK 9.33

Moberg Pharma

7D

7.3%

1Y

-63.4%

Shareholders Will Probably Hold Off On Increasing Moberg Pharma AB (publ)'s (STO:MOB) CEO Compensation For The Time Being

May 16
Shareholders Will Probably Hold Off On Increasing Moberg Pharma AB (publ)'s (STO:MOB) CEO Compensation For The Time Being

FLERIE

SEK 42.70

Flerie

7D

-3.1%

1Y

n/a

IBT B

SEK 56.70

Infant Bacterial Therapeutics

7D

-2.1%

1Y

-43.2%

STABL

SEK 0.52

Stayble Therapeutics

7D

29.4%

1Y

104.3%

ALZCUR

SEK 2.93

AlzeCure Pharma

7D

13.1%

1Y

43.6%

ENZY

SEK 2.93

Enzymatica

7D

-4.9%

1Y

-7.3%

ACUC

SEK 0.89

AcuCort

7D

4.7%

1Y

-3.3%